ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
PhaseBio Pharmaceuticals Inc

PhaseBio Pharmaceuticals Inc (PHAS)

0.0701
0.00
( 0.00% )
Updated: 19:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0701
Bid
0.0645
Ask
0.0671
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.0701
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

PHAS Latest News

PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code

Bidding Process and Auction Projected to Conclude December 2022 PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and...

PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today...

PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab

PhaseBio recently received formal written minutes from the FDA following its Pre-BLA Meeting held in early April and is expecting to submit its Biologics License Application (BLA) by early in the...

PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today...

PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab

Results presented on April 2nd during a Late Breaking Featured Clinical Research Presentation at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22) Trial achieved...

PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights

Achieved key clinical milestones for bentracimab program, with positive results from both the completed Phase 2b trial and interim analysis of the ongoing REVERSE-IT global Phase 3 trial Company...

PhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Update

Manufacturing of bentracimab drug substance and drug product Process Performance Qualification (PPQ) batches has been completed PhaseBio remains on track to submit bentracimab Biologics License...

PhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care Conference

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today...

PhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific Session

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AALAmerican Airlines Group Inc
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AALAmerican Airlines Group Inc
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

Discussion

View Full Feed
Kool Aid Man Kool Aid Man 5 minutes ago
Park-n-Team hold ZERO shares...yet spend money like drunken sailors provided them by "charitable donations & mystery loans" ..and make repeated, outlandish PR's that are possibly illegal because.......???
SPZI
MightyX MightyX 5 minutes ago
Of the many legit inherent OTC-risks..trader-group-fraud isn’t one.
TPTW
Matt24777 Matt24777 6 minutes ago
VOLUME 105,000
PLYZ
m0n m0n 6 minutes ago
Your desperation is comical claiming defamation of character on this board LoL


IFUS
Jagman5 Jagman5 6 minutes ago
This is very positive news. The company they chose, GMP, has significant experience with this type project and a positive reputation.

$BIOF
BIOF
236T568 236T568 6 minutes ago
Trump announces reparations for white people.

https://x.com/keithboykin/status/1856396150011768837
stoneroad stoneroad 6 minutes ago
Hate to say it, but cubflyer was right about these a-holes.
CDMO
blownaccount9 blownaccount9 6 minutes ago
Amelia exited too which is pretty funny


@Navy Fmcc and fnma are trading equally- are you going to swap back??
FNMA
MightyX MightyX 6 minutes ago
Legit inherent OTC risk. No blame game except against trader-group-fraud trying to separate you from your shares.
TPTW
dinogreeves dinogreeves 7 minutes ago
So, you are saying that this could potentially be Nasdaq bound with starting price of $1.00 dollar after possibly a 100-1 reverse split just to list on Nasdaq?
AFFU
Tr8dervic Tr8dervic 7 minutes ago
Received gift cards from McLightning and Dave4G. Thank you!
fuagf fuagf 7 minutes ago
Everyone Trump Has Picked to Join His Second Administration

"Let's be faithful to USA - 5 things you need to know about Susie Wiles
" Cost of living/ immigration -- Voters Were Fed Up Over Immigration. They Voted for Trump.""

The president-elect isn't wasting ti
zeusgodmd zeusgodmd 7 minutes ago
2 million shares recovered hopefully Vrnof got half of them
VRNOF
Penny Stocks 2.0 Penny Stocks 2.0 7 minutes ago
I think mm are in panic mode.
ABIT
Hercules1 Hercules1 7 minutes ago
damn straight bro.

i can hardly wait to add more to my stash here tomorrow.

we may be rocketing to .30 to .40 tomorrow.
ABIT
cheusmann cheusmann 8 minutes ago
I saw that. Very odd. A good sign? it seems to be. They're really trying to hold this back.
ABIT
ShawnP123 ShawnP123 8 minutes ago
Today anything is possible as far as what is being done. However, I'm not convinced Jensen is as unscrupulous as the site might suggest. I will wait for the Q and K before making any decisions. One thing I look for is a term which states standard accounting principles. I also am cautious with terms
NVDA
Penny Stocks 2.0 Penny Stocks 2.0 8 minutes ago
What's going on with the L2...it's gapping after hours, weird. $ABIT
ABIT
Hercules1 Hercules1 9 minutes ago
wow.

what an awesome close.


most people have not seen the new positions opening up at this company.

they are growing by leaps and bounds.


stock is still flying under the radar.


ABIT
GBR GBR 9 minutes ago
and another consulting components added to AWS Marketplace.

https://aws.amazon.com/marketplace/pp/prodview-kqz4rrgy2bmoi?sr=0-8&ref_=beagle&applicationId=AWSMPContessa
VERI
Golfbum22 Golfbum22 9 minutes ago
2.81 close for both gse’s

No delta

Hmmm

Go FnF
FMCC
georgejjl georgejjl 9 minutes ago
AVXL closed at $9.02 per share.

Good luck and GOD bless.
AVXL
IronChefQuezon IronChefQuezon 9 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175371792
APRU
KVM KVM 9 minutes ago
Lackluster revenues was of result of lackluster hiring, decline of AWS revenue and supposed delay of Fed contracts. I am really not sure how Aiware fits into any of this. They hyped it a little on call and trying g to hook up with other major Ai providers. So again who knows. But #s tucked and would
VERI